MALAT1 and BACH1 are prognostic biomarkers for triple-negative breast cancer

• Published in: Journal of cancer research and therapeutics Vol. 15; no. 7; pp. 1597 - 1602
• Main Authors: Ou, Xueqi, Gao, Guanfeng, Bazhabayi, Meiheban, Zhang, Kaiming, Liu, Feng, Xiao, Xiangsheng
• Format: Journal Article
• Language: English
• Published: India Wolters Kluwer India Pvt. Ltd 01.01.2019; Medknow Publications and Media Pvt. Ltd; Medknow Publications & Media Pvt. Ltd
• Subjects: Adult; Analysis; Basic-Leucine Zipper Transcription Factors - genetics; Basic-Leucine Zipper Transcription Factors - metabolism; Biological markers; Biomarkers, Tumor; Breast cancer; Cancer therapies; Care and treatment; Cell Line, Tumor; Chemotherapy; Female; Gene Expression; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lung cancer; Lymphatic system; Medical prognosis; Metabolism; Metastasis; Middle Aged; Neoplasm Staging; Ovarian cancer; Patients; Prognosis; RNA, Long Noncoding - genetics; RNA, Long Noncoding - metabolism; Studies; Survival analysis; Triple Negative Breast Neoplasms - diagnosis; Triple Negative Breast Neoplasms - genetics; Triple Negative Breast Neoplasms - metabolism; Triple Negative Breast Neoplasms - mortality; Tumors; China; triple-negative breast cancer; metastasis-associated lung adenocarcinoma transcript 1; prognosis; BTB and CNC homology 1

Aims: The purpose of this study was to investigate the potential correlation between metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) and the transcription factor BTB and CNC homology 1 (BACH1) and their clinicopathological significance in triple-negative breast cancer (TNBC). Subject...